title: Tuberculosis vaccines: time for a global strategy.
authors.affiliation: Department of Immunology, Max Planck Institute for Infection Biology, D-10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de.
authors.forename: Stefan H E
authors.initials: SH
authors.lastname: Kaufmann
authors.affiliation: Aeras, Rockville, MD 20850, USA.
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Evans
authors.affiliation: Bill & Melinda Gates Foundation, Seattle, WA 98109, USA.
authors.forename: Willem A
authors.initials: WA
authors.lastname: Hanekom
mesh_terms: D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D006801:Humans; D038622:Internationality; D032581:Tuberculosis Vaccines / Q000191:economics / Q000276:immunology*
chemical_list: D032581:Tuberculosis Vaccines